Condition
Severe Burn
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04264065RecruitingPrimary
Albumin and Prognosis of Severely Patients Burns
NCT02638779Not ApplicableCompleted
REAnimation Low Immune Status Markers
NCT06670248Recruiting
Evaluation of Endothelial Glycocalyx in the Surgical Resuscitation of Major Burn Patients
NCT03379116CompletedPrimary
A Study on Nutrition Support in Adult Patients With Severe Burns
NCT03335137Completed
Determining Drug Levels of Beta-lactam Antibiotics in Severe Burned Patients
Showing all 5 trials